Eagle Pharmaceuticals, Inc. Operating Lease, Liability, Noncurrent
Eagle Pharmaceuticals, Inc. had Operating Lease, Liability, Noncurrent of $839.00 thousand as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2023-08-09
- 2023-06-30: Operating Lease, Liability, Noncurrent $839.00K.
- 2023-03-31: Operating Lease, Liability, Noncurrent $1.05M.
- 2022-12-31: Operating Lease, Liability, Noncurrent $1.51M.
- 2022-09-30: Operating Lease, Liability, Noncurrent $1.87M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2023-06-30 | $839.00K 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $1.05M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.51M 10-K · filed 2023-03-23 |
| 2022-09-30 | $1.87M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.26M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.56M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $2.90M 10-K · filed 2022-03-08 |
| 2021-09-30 | $3.05M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $3.36M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $3.66M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.96M 10-K · filed 2021-03-05 |
| 2020-09-30 | $2.84M 10-Q · filed 2020-11-02 |
| 2019-12-31 | $3.00M 10-Q · filed 2020-11-02 |
| 2019-09-30 | $3.23M 10-Q · filed 2020-11-02 |
| 2019-03-31 | $2.87M 10-Q · filed 2019-05-07 |